Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) has been rated a Buy by the First Call Corporation. The rating information was based on the First Call equity research recommendation.
Analysts from various Brokerage Firms have rated the company and commented on its price target. Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) stock has received a short term price target of $ 12.67 from 3 Analyst. The share price can be expected to fluctuate from the mean short term target, can be seen from the standard deviation reading of $4.04. The higher estimate of target price is $15 , while the lower price target estimate is $8.
Analysts from various Brokerage Firms have rated the company and commented on its price target. Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) stock has received a short term price target of $ 12.67 from 3 Analyst. The share price can be expected to fluctuate from the mean short term target, can be seen from the standard deviation reading of $4.04. The higher estimate of target price is $15 , while the lower price target estimate is $8.
选择“Disable on www.wenxuecity.com”
选择“don't run on pages on this domain”
